Seoul, Seoul-t'ukpyolsi, South Korea We can highlight the next thriving fund investment areas, such as Medical Device, Internet. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Curiox Biosystems, Alodokter. The fund has exact preference in a number of founders of portfolio startups.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the Dayli Partners, startups are often financed by Lim Der Shing, Golden Gate Ventures, 500 Startups. The meaningful sponsors for the fund in investment in the same round are Softbank Ventures Asia, Sequis Life, SV Investment Partners.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in 2-6 investment rounds annually. The important activity for fund was in 2019.
Related Funds
| Fund Name | Location |
| Alticor Corporate Enterprises | Ada, Michigan, United States |
| Amadeo | New York, New York, United States |
| Barksdale Group | California, Menlo Park, United States |
| Besunyen (Beijing Outsell Health) | China, Guangdong, Wanchai |
| Broadfin Capital | New York, New York, United States |
| Cogepa | France, Ile-de-France, Paris |
| Dai-Dan | Japan, Osaka, Osaka Prefecture |
| Fortune Venture Investment Group | Taipei, Taiwan |
| GrowthWorks Commercialization Fund | Canada, Halifax, Nova Scotia |
| Guoqian Venture Capital | China, Haimen, Jiangsu |
| LAB Miami Ventures | Florida, Miami, United States |
| Long Star Growth | - |
| Next Tech LLC | Pennsylvania, Philadelphia, United States |
| Rage Capital | - |
| Serica Partners | - |
| Shunying Capital | China, Guangdong, Zhuhai |
| Susquehanna International Group (SIG) | Bala Cynwyd, Pennsylvania, United States |
| Tau Consortium | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Medipixel | $14M | 26 Oct 2023 | South Korea, Gyeonggi-do, South Korea | ||
CURAUM | $9M | 26 Sep 2023 | Daejeon, Taejon-jikhalsi, South Korea | ||
K-Cell | 01 Jan 2023 | Kyonggi-do, Gyeonggi-do, South Korea | |||
NUVI lab | $7M | 07 Sep 2022 | Kyonggi-do, Gyeonggi-do, South Korea | ||
HMC Networks | $1M | 07 Jul 2022 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
DeepCardio | $34M | 17 Feb 2022 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Seawith | $870K | 15 Feb 2022 | Daegu, Taegu-jikhalsi, South Korea | ||
iN Therapeutics | $22M | 07 Feb 2022 | Kyonggi-do, Gyeonggi-do, South Korea | ||
LaSemilla | 01 Jan 2022 | Kangwon-do, Gangwon-do, South Korea |
– GenEdit has closed a $26m Series A financing.
– New investors include Eli Lilly, KTB Network, Company K Partners, Korea Investment Partners, DAYLI Partners, KB Investment, IMM Investment, and TIMEFOLIO Asset Management.
– The funding will support the further development of GenEdit’s NanoGalaxy™ platform of non-viral, non-lipid polymer nanoparticles, and the selection for clinical development of therapeutic candidates targeting diseases of the nervous system.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Medipixel | $14M | 26 Oct 2023 | South Korea, Gyeonggi-do, South Korea | ||
CURAUM | $9M | 26 Sep 2023 | Daejeon, Taejon-jikhalsi, South Korea | ||
K-Cell | 01 Jan 2023 | Kyonggi-do, Gyeonggi-do, South Korea | |||
NUVI lab | $7M | 07 Sep 2022 | Kyonggi-do, Gyeonggi-do, South Korea | ||
HMC Networks | $1M | 07 Jul 2022 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
DeepCardio | $34M | 17 Feb 2022 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Seawith | $870K | 15 Feb 2022 | Daegu, Taegu-jikhalsi, South Korea | ||
iN Therapeutics | $22M | 07 Feb 2022 | Kyonggi-do, Gyeonggi-do, South Korea | ||
LaSemilla | 01 Jan 2022 | Kangwon-do, Gangwon-do, South Korea |
